Quarter Financials
Emmaus Life Sciences, Inc. (EMMA)
$0.4
-0.04 (-9.09%)
Income Statement
Balance Sheet
Cash Flow
|
Year
|
2022 Q3
|
2022 Q2
|
2022 Q1
|
2021 Q4
|
2021 Q3
|
2021 Q2
|
2021 Q1
|
2020 Q4
|
|---|
| Net Income | -0 | -9 | -2 | -7 | -3 | 2 | -8 | -1 |
|---|
| Dividend Paid | - | - | - | - | - | - | - | - |
|---|
| Retained Earnings | -253 | -252 | -243 | -241 | -234 | -231 | -234 | -225 |
|---|
|
Year
|
2022 Q3
|
2022 Q2
|
2022 Q1
|
2021 Q4
|
2021 Q3
|
2021 Q2
|
2021 Q1
|
2020 Q4
|
|---|
| Capital Expenditure | - | -0 | -0 | -0 | -0 | - | - | -26 |
|---|
| Net PPE | 3 | 3 | 3 | 4 | 4 | 4 | 4 | 4 |
|---|
|
Year
|
2022 Q3
|
2022 Q2
|
2022 Q1
|
2021 Q4
|
2021 Q3
|
2021 Q2
|
2021 Q1
|
2020 Q4
|
|---|
| New Purchases | - | - | - | - | - | - | - | - |
|---|
| Intangible and Goodwill | - | - | - | - | - | - | - | - |
|---|